Year: 2012
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Autism spectrum disorders (ASDs) are highly heritable neurodevelopmental disorders that onset clinically during the first years of life. ASD risk biomarkers expressed early in life could significantly impact diagnosis and treatment, but no transcriptome-wide biomarker classifiers derived from fresh blood samples from children with autism have yet emerged. METHOD: Using a community-based, prospective, longitudinal method, we identified 60 infants and toddlers at risk for ASDs (autistic disorder and pervasive developmental disorder), 34 at-risk for language delay, 17 at-risk for global developmental delay, and 68 typically developing comparison children. Diagnoses were confirmed via longitudinal follow-up. Each child's mRNA expression profile in peripheral blood mononuclear cells was determined by microarray. RESULTS: Potential ASD biomarkers were discovered in one-half of the sample and used to build a classifier, with high diagnostic accuracy in the remaining half of the sample. CONCLUSIONS: The mRNA expression abnormalities reliably observed in peripheral blood mononuclear cells, which are safely and easily assayed in infants, offer the first potential peripheral blood-based, early biomarker panel of risk for autism in infants and toddlers. Future work should verify these biomarkers and evaluate whether they may also serve as indirect indices of deviant molecular neural mechanisms in autism.
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,710
Funders: State University of New York, Louis and Harold Price Foundation, National Alliance for Research on Schizophrenia and Depression, National Institutes of Health, State University of New York Upstate Medical University, National Institute on Aging, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Neurological Disorders and Stroke, National Center for Research Resources
Awards: Imaging Studies in Neurotoxicity and Neurodevelopment, Structural & Metabolic Neuroimaging Biomarkers in Early Alzheimer's Disease, Creating a Pediatric Imaging-Genomics Data Resource, G25173860, CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER), Genomic Association Study of Bipolar Disorder, Schizophrenia Biomarkers: Blood vs Brain Gene Expression, Scripps Translational Science Institute (UL1), Substance Abuse & Behavioral Disinhibition: Integrating Genes & Environment, Early Identification of ASD: Translating Eye Tracking into Practice, Biomarkers of Autism at 12 months: From Brain Overgrowth to Genes, G9000065455, Longevity Consortium
OpenAlex ID: W1988426780
